abstract |
A compound of formula I or a pharmaceutically acceptable salt thereof: Wherein m, n, R 1 , R 2 , R 3 , R 4 , R 5 and R a are as defined herein. Also disclosed are methods of making the compounds and methods of using the compounds for the treatment of P2X7 purinergic receptor related diseases. |